Canadian firm Canopy Growth Corp, is seeking to spend over €100m in the European Union in its wider plans to grow medical marijuana. The company, worth around €9bn, wants to build two new production facilities to grow hundreds of kilos of cannabis for use in treatment. The company
told BNN Bloomberg news that, outside Canada, Germany and the EU has one of the most exciting regulated medical cannabis markets.